Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic erythromycin derivatives

Tricyclic erythromycin derivatives

US Patent 6274715 · Granted Aug 14, 2001

Estimated economic value: $108,977,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antiviral heterocyclic compounds2025
Hepatitis B antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use there2025
Antiviral heterocyclic compounds2025
Benzodiazepine derivatives as RSV inhibitors2025
Indane derivatives for use in the treatment of bacterial infection2025
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof2025
Combination pharmaceutical agents as RSV inhibitors2025
Functionalized heterocycles as antiviral agents2025